BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Biotech Bay

  2 Biotechs Under $5 Bucks Investors Should Put on Their Watchlists

  Why investors may want to keep an eye on Idera Pharmaceuticals and Ekso Bionics.

  December 4, 2017

   · 

  1 min read
• 

  Business

  Little Idorsia Scores $230M+ R&D Deal With Johnson & Johnson

  Today, Janssen Biotech announced it had exercised its option to enter into a collaboration deal with Idorsia to jointly develop and market aprocitentan and any derivative compounds.

  December 4, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Ultragenyx Stock Booms After Burosumab Continues to Impress in Phase III Study

  Shares of Ultragenyx are sharply climbing this morning after the company announced positive results from its Phase III study of burosumab in adults with XLH.

  December 4, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Biotech Beach

  4 Solid Biotechs to Load Up on This Month

  Barring a huge meltdown, the S&P 500 will once again have a double-digit year of gains, and most investors should be looking at their 401(k)s and other accounts with some added holiday cheer.

  December 4, 2017

   · 

  1 min read
• 

  Deals

  Exactech Gets Sweetened $737M Cash Deal From TPG Capital

  The revised offer of $49.25 per share represents an increase of 17.3 percent to the previously announced $42 per share, the company said.

  December 4, 2017

   · 

  1 min read
• 

  Business

  What You Need to Know About CBT Pharmaceuticals

  Based in Santa Clara, California, CBT Pharma was spun out of Crown Bioscience with four development-stage assets in the oncology space.

  December 4, 2017

   · 

  4 min read

   · 

  Mark Terry
• 

  BioMidwest

  Life Science’s Fastest Growing Job Right Now

  A look at the one position that stands out for its role in the biopharma industry.

  December 4, 2017

   · 

  4 min read

   · 

  Mark Terry
• 

  Bio NC

  Top 20 Life Science Startups to Watch in 2018

  BioSpace is proud to present its NextGen “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.

  December 4, 2017

   · 

  9 min read

   · 

  Mark Terry
• 

  Drug Development

  Ra Pharma Crashed as Certain Patients Failed to Tolerate Switch From Alexion’s Soliris

  The patients who were transfusion dependent and switched from Soliris were forced to switch back to the Alexion drug.

  December 4, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  The Philippines Suspends Sanofi’s Dengue Vaccine After 730,000+ Children are Immunized

  Sanofi said the analysis showed more cases of severe disease could occur following vaccination in patients who had not been previously infected by the dengue virus.

  December 4, 2017

   · 

  2 min read

   · 

  Alex Keown